title: Is widespread screening for hepatitis C justified?
authors.affiliation: David Geffen-UCLA School of Medicine, CA, USA.
authors.forename: Ronald L
authors.initials: RL
authors.lastname: Koretz
authors.affiliation: Georgetown University School of Medicine, Washington, DC, USA.
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Lin
authors.affiliation: Stanford University, CA, USA.
authors.forename: John P A
authors.initials: JP
authors.lastname: Ioannidis
authors.affiliation: New York, USA jeanne.lenzer@gmail.com.
authors.forename: Jeanne
authors.initials: J
authors.lastname: Lenzer
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D006526:Hepatitis C / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D014481:United States
chemical_list: D000998:Antiviral Agents